Back to results
US 2009/0293152 A1Published application
Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
AssigneeEi and Pioneer Hi-Bred International
InventorsKEITH ROESLER, HOWARD GLENN DAMUDE, CHANGJIANG LI, KNUT MEYER, BO SHEN, ERICKA BERMUDEZ, MITCHELL C. TARCZYNSKI
Life of this patent
Estimating the term…
Abstract
Transgenic oilseeds having increased total fatty acid content of at least 10% and altered fatty acid profiles when compared to the total fatty acid content of null segregant oilseeds are described. Novel DGAT genes are used to achieve the increase in seed storage lipids.
Claims25
An isolated polynucleotide comprising:
- (a) a nucleotide sequence encoding a polypeptide having diacylglycerol acyltransferase activity wherein the polypeptide has at least 80% amino acid identity, based on the Clustal V method of alignment, when compared to an amino acid sequence as set forth in SEQ ID NOs:8, 10, or 12;
- (b) a nucleotide sequence encoding a polypeptide having diacylglycerol acyltransferase activity, wherein the nucleotide sequence has at least 80% sequence identity, based on the BLASTN method of alignment, when compared to a nucleotide sequence as set forth in SEQ ID NO:
- 7, 9, or 11:
- (c) a nucleotide sequence encoding a polypeptide having diacylglycerol acyltransferase activity, wherein the nucleotide sequence hybridizes under stringent conditions to a nucleotide sequence as set forth in SEQ ID NO:
- 7, 9, or 11;
- or
- (d) a complement of the nucleotide sequence of (a), (b) or (c), wherein the complement and the nucleotide sequence consist of the same number of nucleotides and are 100% complementary.
4 more elements
A transgenic oilseed having an increased total fatty acid content of at least 10% when compared to the total fatty acid content of a null segregant oilseed, wherein said transgenic oilseed comprises a recombinant construct having at least one type 1 plant DGAT sequence obtained from one or more edible nuts.
A method for increasing the total fatty acid content of an oilseed cell comprising:
- (a) obtaining an isolated nucleic acid fragment encoding a modified Type 1 diacylglycerol acyltransferase polypeptide such that the modified Type 1 diacylglycerol acyltransferase polypeptide has at least one amino acid substitution selected from the group consisting of:
- a non-alanine at a position corresponding to position 12 of SEQ ID NO:12 to alanine,
- a non-proline at a position corresponding to position 30 of SEQ ID NO:12 to proline,
- a non-alanine at a position corresponding to position 31 of SEQ ID NO:12 to alanine,
- a non-serine at a position corresponding to position 48 of SEQ ID NO:12 to serine,
- a non-serine at a position corresponding to position 49 of SEQ ID NO:12 to serine,
- a non-aspartate at a position corresponding to position 51 of SEQ ID NO:12 to aspartate,
- a non-aspartate at a position corresponding to position 52 of SEQ ID NO:12 to aspartate,
- a non-threonine at a position corresponding to position 59 of SEQ ID NO:12 to threonine,
- a non-threonine at a position corresponding to position 73 of SEQ ID NO:12 to threonine,
- a non-asparagine at a position corresponding to position 79 of SEQ ID NO:12 to asparagine,
- a non-leucine at a position corresponding to position 118 of SEQ ID NO:12 to leucine,
- a non-alanine at a position corresponding to position 123 of SEQ ID NO:12 to alanine,
- a non-valine at a position corresponding to position 128 of SEQ ID NO:12 to valine,
- a non-leucine at a position corresponding to position 139 of SEQ ID NO:12 to leucine,
- a non-isoleucine at a position corresponding to position 155 of SEQ ID NO:12 to isoleucine,
- a non-alanine at a position corresponding to position 181 of SEQ ID NO:12 to alanine,
- a non-serine at a position corresponding to position 184 of SEQ ID NO:12 to serine,
- a non-valine at a position corresponding to position 197 of SEQ ID NO:12 to valine,
- a non-valine at a position corresponding to position 198 of SEQ ID NO:12 to valine,
- a non-methionine at a position corresponding to position 205 of SEQ ID NO:12 to methionine,
- a non-threonine at a position corresponding to position 211 of SEQ ID NO:12 to threonine,
- a non-histidine at a position corresponding to position 218 of SEQ ID NO:12 to histidine,
- a non-valine at a position corresponding to position 222 of SEQ ID NO:12 to valine,
- a non-lysine at a position corresponding to position 241 of SEQ ID NO:12 to lysine,
- a non-valine at a position corresponding to position 247 of SEQ ID NO:12 to valine,
- a non-valine at a position corresponding to position 251 of SEQ ID NO:12 to valine,
- a non-serine at a position corresponding to position 256 of SEQ ID NO:12 to serine,
- a non-serine at a position corresponding to position 257 of SEQ ID NO:12 to serine,
- a non-phenylalanine at a position corresponding to position 266 of SEQ ID NO:12 to phenylalanine,
- a non-alanine at a position corresponding to position 267 of SEQ ID NO:12 to alanine,
- a non-glutamate at a position corresponding to position 281 of SEQ ID NO:12 to glutamate,
- a non-aspartate at a position corresponding to position 288 of SEQ ID NO:12 to aspartate,
- a non-glutamate at a position corresponding to position 293 of SEQ ID NO:12 to glutamate,
- a non-asparagine at a position corresponding to position 294 of SEQ ID NO:12 to asparagine,
- a non-threonine at a position corresponding to position 299 of SEQ ID NO:12 to threonine,
- a non-asparagine at a position corresponding to position 301 of SEQ ID NO:12 to asparagine,
- a non-leucine at a position corresponding to position 308 of SEQ ID NO:12 to leucine,
- a non-glycine at a position corresponding to position 327 of SEQ ID NO:12 to glycine,
- a non-leucine at a position corresponding to position 329 of SEQ ID NO:12 to leucine,
- a non-leucine at a position corresponding to position 334 of SEQ ID NO:12 to leucine,
- a non-valine at a position corresponding to position 337 of SEQ ID NO:12 to valine,
- a non-valine at a position corresponding to position 338 of SEQ ID NO:12 to valine,
- a non-glutamine at a position corresponding to position 356 of SEQ ID NO:12 to glutamine,
- a non-asparagine at a position corresponding to position 363 of SEQ ID NO:12 to asparagine,
- a non-serine at a position corresponding to position 390 of SEQ ID NO:12 to serine,
- a non-valine at a position corresponding to position 399 of SEQ ID NO:12 to valine,
- a non-isoleucine at a position corresponding to position 436 of SEQ ID NO:12 to isoleucine,
- a non-alanine at a position corresponding to position 451 of SEQ ID NO:12 to alanine,
- a non-serine at a position corresponding to position 457 of SEQ ID NO:12 to serine,
- a non-methionine at a position corresponding to position 475 of SEQ ID NO:12 to methionine,
- a non-phenylalanine at a position corresponding to position 486 of SEQ ID NO:12 to phenylalanine,
- a non-isoleucine at a position corresponding to position 488 of SEQ ID NO:12 to isoleucine,
- a non-leucine at a position corresponding to position 491 of SEQ ID NO:12 to leucine,
- a non-lysine at a position corresponding to position 502 of SEQ ID NO:12 to lysine,
- a non-serine at a position corresponding to position 514 of SEQ ID NO:12 to serine,
- a non-valine at a position corresponding to position 518 of SEQ ID NO:12 to valine, and
- a non-valine at a position corresponding to position 531 of SEQ ID NO:12 to valine,
- when compared to the unmodified Type 1 diacylglycerol acyltransferase polypeptide, wherein the position corresponding to a position of SEQ ID NO:12 is based on an alignment using Clustal V of SEQ ID NO:12 and the unmodified Type 1 diacylglycerol acyltransferase polypeptide;
- (b) making a recombinant DNA construct comprising the isolated nucleic acid fragment of part (a) operably linked to at least one regulatory sequence;
- (c) transforming at least one oilseed cell with the recombinant construct of part (c);
- and
- (d) selecting the transformed oilseed cell(s) of step (c) having an increased total fatty acid content when compared to the total fatty acid content of a null segregant oilseed cell.
60 more elements
A method for increasing the total fatty acid content of an oilseed cell comprising:
- (a) obtaining an isolated nucleic acid fragment encoding a modified Type 1 diacylglycerol acyltransferase polypeptide such that the modified Type 1 diacylglycerol acyltransferase polypeptide has at least one amino acid substitution selected from the group consisting of:
- a non-alanine at a position corresponding to position 24 of SEQ ID NO:153 to alanine,
- a non-asparagine at a position corresponding to position 58 of SEQ ID NO:153 to asparagine,
- a non-alanine at a position corresponding to position 146 of SEQ ID NO:153 to alanine,
- a non-methionine at a position corresponding to position 170 of SEQ ID NO:153 to methionine,
- a non-lysine at a position corresponding to position 206 of SEQ ID NO:153 to lysine,
- a non-valine at a position corresponding to position 216 of SEQ ID NO:153 to valine,
- a non-phenylalanine at a position corresponding to position 231 of SEQ ID NO:153 to phenylalanine,
- a non-glutamate at a position corresponding to position 258 of SEQ ID NO:153 to glutamate,
- a non-threonine at a position corresponding to position 264 of SEQ ID NO:153 to threonine,
- a non-leucine at a position corresponding to position 273 of SEQ ID NO:153 to leucine,
- a non-leucine at a position corresponding to position 299 of SEQ ID NO:153 to leucine,
- a non-valine at a position corresponding to position 303 of SEQ ID NO:153 to valine,
- a non-serine at a position corresponding to position 355 of SEQ ID NO:153 to serine,
- a non-valine at a position corresponding to position 364 of SEQ ID NO:153 to valine,
- a non-arginine at a position corresponding to position 401 of SEQ ID NO:153 to arginine,
- a non-serine at a position corresponding to position 422 of SEQ ID NO:153 to serine,
- a non-methionine at a position corresponding to position 440 of SEQ ID NO:153 to methionine,
- a non-lysine at a position corresponding to position 467 of SEQ ID NO:153 to lysine,
- a non-serine at a position corresponding to position 479 of SEQ ID NO:153 to serine,
- a non-valine at a position corresponding to position 483 of SEQ ID NO:153 to valine,
- when compared to the unmodified Type 1 diacylglycerol acyltransferase polypeptide, wherein the position corresponding to a position of SEQ ID NO:153 is based on an alignment using Clustal V of SEQ ID NO:153 and the unmodified Type 1 diacylglycerol acyltransferase polypeptide;
- (b) making a recombinant DNA construct comprising the isolated nucleic acid fragment of part (a) operably linked to at least one regulatory sequence;
- (c) transforming at least one oilseed cell with the recombinant construct of part (c);
- and
- (d) selecting the transformed oilseed cell(s) of step (c) having an increased total fatty acid content when compared to the total fatty acid content of a null segregant oilseed cell.
23 more elements
An isolated nucleic acid fragment encoding a modified Type 1 diacylglycerol acyltransferase polypeptide such that the modified Type 1 diacylglycerol acyltransferase polypeptide has at least one amino acid substitution selected from the group consisting of:
- a non-alanine at a position corresponding to position 12 of SEQ ID NO:12 to alanine,
- a non-proline at a position corresponding to position 30 of SEQ ID NO:12 to proline,
- a non-alanine at a position corresponding to position 31 of SEQ ID NO:12 to alanine,
- a non-serine at a position corresponding to position 48 of SEQ ID NO:12 to serine,
- a non-serine at a position corresponding to position 49 of SEQ ID NO:12 to serine,
- a non-aspartate at a position corresponding to position 51 of SEQ ID NO:12 to aspartate,
- a non-aspartate at a position corresponding to position 52 of SEQ ID NO:12 to aspartate,
- a non-threonine at a position corresponding to position 59 of SEQ ID NO:12 to threonine,
- a non-threonine at a position corresponding to position 73 of SEQ ID NO:12 to threonine,
- a non-asparagine at a position corresponding to position 79 of SEQ ID NO:12 to asparagine,
- a non-leucine at a position corresponding to position 118 of SEQ ID NO:12 to leucine,
- a non-alanine at a position corresponding to position 123 of SEQ ID NO:12 to alanine,
- a non-valine at a position corresponding to position 128 of SEQ ID NO:12 to valine,
- a non-leucine at a position corresponding to position 139 of SEQ ID NO:12 to leucine,
- a non-isoleucine at a position corresponding to position 155 of SEQ ID NO:12 to isoleucine,
- a non-alanine at a position corresponding to position 181 of SEQ ID NO:12 to alanine,
- a non-serine at a position corresponding to position 184 of SEQ ID NO:12 to serine,
- a non-valine at a position corresponding to position 197 of SEQ ID NO:12 to valine,
- a non-valine at a position corresponding to position 198 of SEQ ID NO:12 to valine,
- a non-methionine at a position corresponding to position 205 of SEQ ID NO:12 to methionine,
- a non-threonine at a position corresponding to position 211 of SEQ ID NO:12 to threonine,
- a non-histidine at a position corresponding to position 218 of SEQ ID NO:12 to histidine,
- a non-valine at a position corresponding to position 222 of SEQ ID NO:12 to valine,
- a non-lysine at a position corresponding to position 241 of SEQ ID NO:12 to lysine,
- a non-valine at a position corresponding to position 247 of SEQ ID NO:12 to valine,
- a non-valine at a position corresponding to position 251 of SEQ ID NO:12 to valine,
- a non-serine at a position corresponding to position 256 of SEQ ID NO:12 to serine,
- a non-serine at a position corresponding to position 257 of SEQ ID NO:12 to serine,
- a non-phenylalanine at a position corresponding to position 266 of SEQ ID NO:12 to phenylalanine,
- a non-alanine at a position corresponding to position 267 of SEQ ID NO:12 to alanine,
- a non-glutamate at a position corresponding to position 281 of SEQ ID NO:12 to glutamate,
- a non-aspartate at a position corresponding to position 288 of SEQ ID NO:12 to aspartate,
- a non-glutamate at a position corresponding to position 293 of SEQ ID NO:12 to glutamate,
- a non-asparagine at a position corresponding to position 294 of SEQ ID NO:12 to asparagine,
- a non-threonine at a position corresponding to position 299 of SEQ ID NO:12 to threonine,
- a non-asparagine at a position corresponding to position 301 of SEQ ID NO:12 to asparagine,
- a non-leucine at a position corresponding to position 308 of SEQ ID NO:12 to leucine,
- a non-glycine at a position corresponding to position 327 of SEQ ID NO:12 to glycine,
- a non-leucine at a position corresponding to position 329 of SEQ ID NO:12 to leucine,
- a non-leucine at a position corresponding to position 334 of SEQ ID NO:12 to leucine,
- a non-valine at a position corresponding to position 337 of SEQ ID NO:12 to valine,
- a non-valine at a position corresponding to position 338 of SEQ ID NO:12 to valine,
- a non-glutamine at a position corresponding to position 356 of SEQ ID NO:12 to glutamine,
- a non-asparagine at a position corresponding to position 363 of SEQ ID NO:12 to asparagine,
- a non-serine at a position corresponding to position 390 of SEQ ID NO:12 to serine,
- a non-valine at a position corresponding to position 399 of SEQ ID NO:12 to valine,
- a non-isoleucine at a position corresponding to position 436 of SEQ ID NO:12 to isoleucine,
- a non-alanine at a position corresponding to position 451 of SEQ ID NO:12 to alanine,
- a non-serine at a position corresponding to position 457 of SEQ ID NO:12 to serine,
- a non-methionine at a position corresponding to position 475 of SEQ ID NO:12 to methionine,
- a non-phenylalanine at a position corresponding to position 486 of SEQ ID NO:12 to phenylalanine,
- a non-isoleucine at a position corresponding to position 488 of SEQ ID NO:12 to isoleucine,
- a non-leucine at a position corresponding to position 491 of SEQ ID NO:12 to leucine,
- a non-lysine at a position corresponding to position 502 of SEQ ID NO:12 to lysine,
- a non-serine at a position corresponding to position 514 of SEQ ID NO:12 to serine,
- a non-valine at a position corresponding to position 518 of SEQ ID NO:12 to valine, and
- a non-valine at a position corresponding to position 531 of SEQ ID NO:12 to valine,
- when compared to the unmodified Type 1 diacylglycerol acyltransferase polypeptide, wherein the position corresponding to a position of SEQ ID NO:12 is based on an alignment using Clustal V of SEQ ID NO:12 and the unmodified Type 1 diacylglycerol acyltransferase polypeptide.
55 more elements
A n isolated nucleic acid fragment encoding a modified Type 1 diacylglycerol acyltransferase polypeptide such that the modified Type 1 diacylglycerol acyltransferase polypeptide has at least one amino acid substitution selected from the group consisting of:
- a non-alanine at a position corresponding to position 24 of SEQ ID NO:153 to alanine,
- a non-asparagine at a position corresponding to position 58 of SEQ ID NO:153 to asparagine,
- a non-alanine at a position corresponding to position 146 of SEQ ID NO:153 to alanine,
- a non-methionine at a position corresponding to position 170 of SEQ ID NO:153 to methionine,
- a non-lysine at a position corresponding to position 206 of SEQ ID NO:153 to lysine,
- a non-valine at a position corresponding to position 216 of SEQ ID NO:153 to valine,
- a non-phenylalanine at a position corresponding to position 231 of SEQ ID NO:153 to phenylalanine,
- a non-glutamate at a position corresponding to position 258 of SEQ ID NO:153 to glutamate,
- a non-threonine at a position corresponding to position 264 of SEQ ID NO:153 to threonine,
- a non-leucine at a position corresponding to position 273 of SEQ ID NO:153 to leucine,
- a non-leucine at a position corresponding to position 299 of SEQ ID NO:153 to leucine,
- a non-valine at a position corresponding to position 303 of SEQ ID NO:153 to valine,
- a non-serine at a position corresponding to position 355 of SEQ ID NO:153 to serine,
- a non-valine at a position corresponding to position 364 of SEQ ID NO:153 to valine,
- a non-arginine at a position corresponding to position 401 of SEQ ID NO:153 to arginine,
- a non-serine at a position corresponding to position 422 of SEQ ID NO:153 to serine,
- a non-methionine at a position corresponding to position 440 of SEQ ID NO:153 to methionine,
- a non-lysine at a position corresponding to position 467 of SEQ ID NO:153 to lysine,
- a non-serine at a position corresponding to position 479 of SEQ ID NO:153 to serine,
- a non-valine at a position corresponding to position 483 of SEQ ID NO:153 to valine,
- when compared to the unmodified Type 1 diacylglycerol acyltransferase polypeptide, wherein the position corresponding to a position of SEQ ID NO:153 is based on an alignment using Clustal V of SEQ ID NO:153 and the unmodified Type 1 diacylglycerol acyltransferase polypeptide.
18 more elements
Dependencies are inferred from the claim text.